Cell Journal, Spike Walker
Last week’s Supreme Court decision to invalidate patents on human genes was a loss for Myriad Genetics and a win for patients and independent researchers. But the ruling is also a boon the wider biotech industry.
Image of the Day
A light micrograph of a human egg, which is surrounded by a matrix of glycoproteins, called the zona pellucida (brown rim), and a layer of follicle cells, called the corona radiata (yellow).
| November 12, 2012
Advertisement
Add a Comment
You
Processing...
Comments
November 12, 2012
Simple question: Are the small, dark-headed, long thin-tailed cells (I count three of them) in or approaching the corona spermatozoa?
Related Articles
The scientific community and the impact of the Myriad Genetics Supreme Court decision
Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
